INS and type 2 diabetes mellitus: Moreover, although our reported postprandial ICR profile in the type 2 diabetes group is akin to previous findings in people with type 2 diabetes after drug withdrawal [9], as all anti-hyperglycaemic medications were kept unaltered in our study, we cannot exclude the potential effects of concomitant medication use on postprandial insulin kinetics which may cloud our findings.